Summary

The global Cardiovascular Drug Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Cardiovascular Drug Therapy Industry Forecast” looks at past sales and reviews total world Cardiovascular Drug Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Cardiovascular Drug Therapy sales for 2025 through 2031. With Cardiovascular Drug Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiovascular Drug Therapy industry.
This Insight Report provides a comprehensive analysis of the global Cardiovascular Drug Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cardiovascular Drug Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cardiovascular Drug Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiovascular Drug Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiovascular Drug Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Drug Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Oral Medication
Injection
Segmentation by Application:
Hospital
Retail
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Sanofi
Novartis
Bayer
Merck
AstraZeneca
Bristol-Myers
Daiichi Sankyo
Boehringer Ingelheim
Takeda
Johnson & Johnson
United Therapeutics
Gilead
Amgen
Eli Lilly
Zhejiang Huahai Pharmaceutical
Qilu pharmaceutical
CHIA TAI TIANQING
Lepu Medical
CSPC Pharmaceutical
Tasly Holding Group

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cardiovascular Drug Therapy Market Size (2020-2031)
2.1.2 Cardiovascular Drug Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Cardiovascular Drug Therapy by Country/Region (2020, 2024 & 2031)
2.2 Cardiovascular Drug Therapy Segment by Type
2.2.1 Oral Medication
2.2.2 Injection
2.3 Cardiovascular Drug Therapy Market Size by Type
2.3.1 Cardiovascular Drug Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Cardiovascular Drug Therapy Market Size Market Share by Type (2020-2025)
2.4 Cardiovascular Drug Therapy Segment by Application
2.4.1 Hospital
2.4.2 Retail
2.5 Cardiovascular Drug Therapy Market Size by Application
2.5.1 Cardiovascular Drug Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Cardiovascular Drug Therapy Market Size Market Share by Application (2020-2025)
3 Cardiovascular Drug Therapy Market Size by Player
3.1 Cardiovascular Drug Therapy Market Size Market Share by Player
3.1.1 Global Cardiovascular Drug Therapy Revenue by Player (2020-2025)
3.1.2 Global Cardiovascular Drug Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Cardiovascular Drug Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cardiovascular Drug Therapy by Region
4.1 Cardiovascular Drug Therapy Market Size by Region (2020-2025)
4.2 Global Cardiovascular Drug Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cardiovascular Drug Therapy Market Size Growth (2020-2025)
4.4 APAC Cardiovascular Drug Therapy Market Size Growth (2020-2025)
4.5 Europe Cardiovascular Drug Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Cardiovascular Drug Therapy Market Size Growth (2020-2025)
5 Americas
5.1 Americas Cardiovascular Drug Therapy Market Size by Country (2020-2025)
5.2 Americas Cardiovascular Drug Therapy Market Size by Type (2020-2025)
5.3 Americas Cardiovascular Drug Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cardiovascular Drug Therapy Market Size by Region (2020-2025)
6.2 APAC Cardiovascular Drug Therapy Market Size by Type (2020-2025)
6.3 APAC Cardiovascular Drug Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cardiovascular Drug Therapy Market Size by Country (2020-2025)
7.2 Europe Cardiovascular Drug Therapy Market Size by Type (2020-2025)
7.3 Europe Cardiovascular Drug Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cardiovascular Drug Therapy by Region (2020-2025)
8.2 Middle East & Africa Cardiovascular Drug Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Cardiovascular Drug Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cardiovascular Drug Therapy Market Forecast
10.1 Global Cardiovascular Drug Therapy Forecast by Region (2026-2031)
10.1.1 Global Cardiovascular Drug Therapy Forecast by Region (2026-2031)
10.1.2 Americas Cardiovascular Drug Therapy Forecast
10.1.3 APAC Cardiovascular Drug Therapy Forecast
10.1.4 Europe Cardiovascular Drug Therapy Forecast
10.1.5 Middle East & Africa Cardiovascular Drug Therapy Forecast
10.2 Americas Cardiovascular Drug Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Cardiovascular Drug Therapy Forecast
10.2.2 Canada Market Cardiovascular Drug Therapy Forecast
10.2.3 Mexico Market Cardiovascular Drug Therapy Forecast
10.2.4 Brazil Market Cardiovascular Drug Therapy Forecast
10.3 APAC Cardiovascular Drug Therapy Forecast by Region (2026-2031)
10.3.1 China Cardiovascular Drug Therapy Market Forecast
10.3.2 Japan Market Cardiovascular Drug Therapy Forecast
10.3.3 Korea Market Cardiovascular Drug Therapy Forecast
10.3.4 Southeast Asia Market Cardiovascular Drug Therapy Forecast
10.3.5 India Market Cardiovascular Drug Therapy Forecast
10.3.6 Australia Market Cardiovascular Drug Therapy Forecast
10.4 Europe Cardiovascular Drug Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Cardiovascular Drug Therapy Forecast
10.4.2 France Market Cardiovascular Drug Therapy Forecast
10.4.3 UK Market Cardiovascular Drug Therapy Forecast
10.4.4 Italy Market Cardiovascular Drug Therapy Forecast
10.4.5 Russia Market Cardiovascular Drug Therapy Forecast
10.5 Middle East & Africa Cardiovascular Drug Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Cardiovascular Drug Therapy Forecast
10.5.2 South Africa Market Cardiovascular Drug Therapy Forecast
10.5.3 Israel Market Cardiovascular Drug Therapy Forecast
10.5.4 Turkey Market Cardiovascular Drug Therapy Forecast
10.6 Global Cardiovascular Drug Therapy Forecast by Type (2026-2031)
10.7 Global Cardiovascular Drug Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Cardiovascular Drug Therapy Forecast
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Cardiovascular Drug Therapy Product Offered
11.1.3 Pfizer Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Cardiovascular Drug Therapy Product Offered
11.2.3 Sanofi Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Cardiovascular Drug Therapy Product Offered
11.3.3 Novartis Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Cardiovascular Drug Therapy Product Offered
11.4.3 Bayer Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Cardiovascular Drug Therapy Product Offered
11.5.3 Merck Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Cardiovascular Drug Therapy Product Offered
11.6.3 AstraZeneca Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Bristol-Myers
11.7.1 Bristol-Myers Company Information
11.7.2 Bristol-Myers Cardiovascular Drug Therapy Product Offered
11.7.3 Bristol-Myers Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bristol-Myers Main Business Overview
11.7.5 Bristol-Myers Latest Developments
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Company Information
11.8.2 Daiichi Sankyo Cardiovascular Drug Therapy Product Offered
11.8.3 Daiichi Sankyo Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Daiichi Sankyo Main Business Overview
11.8.5 Daiichi Sankyo Latest Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Information
11.9.2 Boehringer Ingelheim Cardiovascular Drug Therapy Product Offered
11.9.3 Boehringer Ingelheim Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Boehringer Ingelheim Main Business Overview
11.9.5 Boehringer Ingelheim Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Cardiovascular Drug Therapy Product Offered
11.10.3 Takeda Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Information
11.11.2 Johnson & Johnson Cardiovascular Drug Therapy Product Offered
11.11.3 Johnson & Johnson Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Johnson & Johnson Main Business Overview
11.11.5 Johnson & Johnson Latest Developments
11.12 United Therapeutics
11.12.1 United Therapeutics Company Information
11.12.2 United Therapeutics Cardiovascular Drug Therapy Product Offered
11.12.3 United Therapeutics Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 United Therapeutics Main Business Overview
11.12.5 United Therapeutics Latest Developments
11.13 Gilead
11.13.1 Gilead Company Information
11.13.2 Gilead Cardiovascular Drug Therapy Product Offered
11.13.3 Gilead Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Gilead Main Business Overview
11.13.5 Gilead Latest Developments
11.14 Amgen
11.14.1 Amgen Company Information
11.14.2 Amgen Cardiovascular Drug Therapy Product Offered
11.14.3 Amgen Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Amgen Main Business Overview
11.14.5 Amgen Latest Developments
11.15 Eli Lilly
11.15.1 Eli Lilly Company Information
11.15.2 Eli Lilly Cardiovascular Drug Therapy Product Offered
11.15.3 Eli Lilly Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Eli Lilly Main Business Overview
11.15.5 Eli Lilly Latest Developments
11.16 Zhejiang Huahai Pharmaceutical
11.16.1 Zhejiang Huahai Pharmaceutical Company Information
11.16.2 Zhejiang Huahai Pharmaceutical Cardiovascular Drug Therapy Product Offered
11.16.3 Zhejiang Huahai Pharmaceutical Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Zhejiang Huahai Pharmaceutical Main Business Overview
11.16.5 Zhejiang Huahai Pharmaceutical Latest Developments
11.17 Qilu pharmaceutical
11.17.1 Qilu pharmaceutical Company Information
11.17.2 Qilu pharmaceutical Cardiovascular Drug Therapy Product Offered
11.17.3 Qilu pharmaceutical Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Qilu pharmaceutical Main Business Overview
11.17.5 Qilu pharmaceutical Latest Developments
11.18 CHIA TAI TIANQING
11.18.1 CHIA TAI TIANQING Company Information
11.18.2 CHIA TAI TIANQING Cardiovascular Drug Therapy Product Offered
11.18.3 CHIA TAI TIANQING Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 CHIA TAI TIANQING Main Business Overview
11.18.5 CHIA TAI TIANQING Latest Developments
11.19 Lepu Medical
11.19.1 Lepu Medical Company Information
11.19.2 Lepu Medical Cardiovascular Drug Therapy Product Offered
11.19.3 Lepu Medical Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Lepu Medical Main Business Overview
11.19.5 Lepu Medical Latest Developments
11.20 CSPC Pharmaceutical
11.20.1 CSPC Pharmaceutical Company Information
11.20.2 CSPC Pharmaceutical Cardiovascular Drug Therapy Product Offered
11.20.3 CSPC Pharmaceutical Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 CSPC Pharmaceutical Main Business Overview
11.20.5 CSPC Pharmaceutical Latest Developments
11.21 Tasly Holding Group
11.21.1 Tasly Holding Group Company Information
11.21.2 Tasly Holding Group Cardiovascular Drug Therapy Product Offered
11.21.3 Tasly Holding Group Cardiovascular Drug Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Tasly Holding Group Main Business Overview
11.21.5 Tasly Holding Group Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Cardiovascular Drug Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Cardiovascular Drug Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral Medication
Table 4. Major Players of Injection
Table 5. Cardiovascular Drug Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Cardiovascular Drug Therapy Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Cardiovascular Drug Therapy Market Size Market Share by Type (2020-2025)
Table 8. Cardiovascular Drug Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Cardiovascular Drug Therapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Cardiovascular Drug Therapy Market Size Market Share by Application (2020-2025)
Table 11. Global Cardiovascular Drug Therapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Cardiovascular Drug Therapy Revenue Market Share by Player (2020-2025)
Table 13. Cardiovascular Drug Therapy Key Players Head office and Products Offered
Table 14. Cardiovascular Drug Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cardiovascular Drug Therapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Cardiovascular Drug Therapy Market Size Market Share by Region (2020-2025)
Table 19. Global Cardiovascular Drug Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Cardiovascular Drug Therapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Cardiovascular Drug Therapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Cardiovascular Drug Therapy Market Size Market Share by Country (2020-2025)
Table 23. Americas Cardiovascular Drug Therapy Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Cardiovascular Drug Therapy Market Size Market Share by Type (2020-2025)
Table 25. Americas Cardiovascular Drug Therapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Cardiovascular Drug Therapy Market Size Market Share by Application (2020-2025)
Table 27. APAC Cardiovascular Drug Therapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Cardiovascular Drug Therapy Market Size Market Share by Region (2020-2025)
Table 29. APAC Cardiovascular Drug Therapy Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Cardiovascular Drug Therapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Cardiovascular Drug Therapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Cardiovascular Drug Therapy Market Size Market Share by Country (2020-2025)
Table 33. Europe Cardiovascular Drug Therapy Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Cardiovascular Drug Therapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Cardiovascular Drug Therapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Cardiovascular Drug Therapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Cardiovascular Drug Therapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cardiovascular Drug Therapy
Table 39. Key Market Challenges & Risks of Cardiovascular Drug Therapy
Table 40. Key Industry Trends of Cardiovascular Drug Therapy
Table 41. Global Cardiovascular Drug Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Cardiovascular Drug Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Cardiovascular Drug Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Cardiovascular Drug Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Pfizer Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 46. Pfizer Cardiovascular Drug Therapy Product Offered
Table 47. Pfizer Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Pfizer Main Business
Table 49. Pfizer Latest Developments
Table 50. Sanofi Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 51. Sanofi Cardiovascular Drug Therapy Product Offered
Table 52. Sanofi Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Sanofi Main Business
Table 54. Sanofi Latest Developments
Table 55. Novartis Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 56. Novartis Cardiovascular Drug Therapy Product Offered
Table 57. Novartis Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Novartis Main Business
Table 59. Novartis Latest Developments
Table 60. Bayer Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 61. Bayer Cardiovascular Drug Therapy Product Offered
Table 62. Bayer Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Bayer Main Business
Table 64. Bayer Latest Developments
Table 65. Merck Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 66. Merck Cardiovascular Drug Therapy Product Offered
Table 67. Merck Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Merck Main Business
Table 69. Merck Latest Developments
Table 70. AstraZeneca Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 71. AstraZeneca Cardiovascular Drug Therapy Product Offered
Table 72. AstraZeneca Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. AstraZeneca Main Business
Table 74. AstraZeneca Latest Developments
Table 75. Bristol-Myers Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 76. Bristol-Myers Cardiovascular Drug Therapy Product Offered
Table 77. Bristol-Myers Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Bristol-Myers Main Business
Table 79. Bristol-Myers Latest Developments
Table 80. Daiichi Sankyo Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 81. Daiichi Sankyo Cardiovascular Drug Therapy Product Offered
Table 82. Daiichi Sankyo Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Daiichi Sankyo Main Business
Table 84. Daiichi Sankyo Latest Developments
Table 85. Boehringer Ingelheim Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 86. Boehringer Ingelheim Cardiovascular Drug Therapy Product Offered
Table 87. Boehringer Ingelheim Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Boehringer Ingelheim Main Business
Table 89. Boehringer Ingelheim Latest Developments
Table 90. Takeda Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 91. Takeda Cardiovascular Drug Therapy Product Offered
Table 92. Takeda Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Takeda Main Business
Table 94. Takeda Latest Developments
Table 95. Johnson & Johnson Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 96. Johnson & Johnson Cardiovascular Drug Therapy Product Offered
Table 97. Johnson & Johnson Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Johnson & Johnson Main Business
Table 99. Johnson & Johnson Latest Developments
Table 100. United Therapeutics Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 101. United Therapeutics Cardiovascular Drug Therapy Product Offered
Table 102. United Therapeutics Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. United Therapeutics Main Business
Table 104. United Therapeutics Latest Developments
Table 105. Gilead Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 106. Gilead Cardiovascular Drug Therapy Product Offered
Table 107. Gilead Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Gilead Main Business
Table 109. Gilead Latest Developments
Table 110. Amgen Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 111. Amgen Cardiovascular Drug Therapy Product Offered
Table 112. Amgen Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Amgen Main Business
Table 114. Amgen Latest Developments
Table 115. Eli Lilly Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 116. Eli Lilly Cardiovascular Drug Therapy Product Offered
Table 117. Eli Lilly Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Eli Lilly Main Business
Table 119. Eli Lilly Latest Developments
Table 120. Zhejiang Huahai Pharmaceutical Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 121. Zhejiang Huahai Pharmaceutical Cardiovascular Drug Therapy Product Offered
Table 122. Zhejiang Huahai Pharmaceutical Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Zhejiang Huahai Pharmaceutical Main Business
Table 124. Zhejiang Huahai Pharmaceutical Latest Developments
Table 125. Qilu pharmaceutical Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 126. Qilu pharmaceutical Cardiovascular Drug Therapy Product Offered
Table 127. Qilu pharmaceutical Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Qilu pharmaceutical Main Business
Table 129. Qilu pharmaceutical Latest Developments
Table 130. CHIA TAI TIANQING Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 131. CHIA TAI TIANQING Cardiovascular Drug Therapy Product Offered
Table 132. CHIA TAI TIANQING Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. CHIA TAI TIANQING Main Business
Table 134. CHIA TAI TIANQING Latest Developments
Table 135. Lepu Medical Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 136. Lepu Medical Cardiovascular Drug Therapy Product Offered
Table 137. Lepu Medical Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Lepu Medical Main Business
Table 139. Lepu Medical Latest Developments
Table 140. CSPC Pharmaceutical Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 141. CSPC Pharmaceutical Cardiovascular Drug Therapy Product Offered
Table 142. CSPC Pharmaceutical Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. CSPC Pharmaceutical Main Business
Table 144. CSPC Pharmaceutical Latest Developments
Table 145. Tasly Holding Group Details, Company Type, Cardiovascular Drug Therapy Area Served and Its Competitors
Table 146. Tasly Holding Group Cardiovascular Drug Therapy Product Offered
Table 147. Tasly Holding Group Cardiovascular Drug Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Tasly Holding Group Main Business
Table 149. Tasly Holding Group Latest Developments


List of Figures
Figure 1. Cardiovascular Drug Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cardiovascular Drug Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Cardiovascular Drug Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Cardiovascular Drug Therapy Sales Market Share by Country/Region (2024)
Figure 8. Cardiovascular Drug Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Cardiovascular Drug Therapy Market Size Market Share by Type in 2024
Figure 10. Cardiovascular Drug Therapy in Hospital
Figure 11. Global Cardiovascular Drug Therapy Market: Hospital (2020-2025) & ($ millions)
Figure 12. Cardiovascular Drug Therapy in Retail
Figure 13. Global Cardiovascular Drug Therapy Market: Retail (2020-2025) & ($ millions)
Figure 14. Global Cardiovascular Drug Therapy Market Size Market Share by Application in 2024
Figure 15. Global Cardiovascular Drug Therapy Revenue Market Share by Player in 2024
Figure 16. Global Cardiovascular Drug Therapy Market Size Market Share by Region (2020-2025)
Figure 17. Americas Cardiovascular Drug Therapy Market Size 2020-2025 ($ millions)
Figure 18. APAC Cardiovascular Drug Therapy Market Size 2020-2025 ($ millions)
Figure 19. Europe Cardiovascular Drug Therapy Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Cardiovascular Drug Therapy Market Size 2020-2025 ($ millions)
Figure 21. Americas Cardiovascular Drug Therapy Value Market Share by Country in 2024
Figure 22. United States Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Cardiovascular Drug Therapy Market Size Market Share by Region in 2024
Figure 27. APAC Cardiovascular Drug Therapy Market Size Market Share by Type (2020-2025)
Figure 28. APAC Cardiovascular Drug Therapy Market Size Market Share by Application (2020-2025)
Figure 29. China Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 33. India Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Cardiovascular Drug Therapy Market Size Market Share by Country in 2024
Figure 36. Europe Cardiovascular Drug Therapy Market Size Market Share by Type (2020-2025)
Figure 37. Europe Cardiovascular Drug Therapy Market Size Market Share by Application (2020-2025)
Figure 38. Germany Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. France Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Cardiovascular Drug Therapy Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Cardiovascular Drug Therapy Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Cardiovascular Drug Therapy Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Cardiovascular Drug Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 52. APAC Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 53. Europe Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 55. United States Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 56. Canada Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 57. Mexico Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 58. Brazil Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 59. China Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 60. Japan Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 61. Korea Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 63. India Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 64. Australia Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 65. Germany Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 66. France Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 67. UK Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 68. Italy Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 69. Russia Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 70. Egypt Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 71. South Africa Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 72. Israel Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 73. Turkey Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)
Figure 74. Global Cardiovascular Drug Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Cardiovascular Drug Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Cardiovascular Drug Therapy Market Size 2026-2031 ($ millions)